Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-03-06 Sale |
2023-03-06 11:40 am |
CONCERT PHARMACEUTICALS INC. | CNCE | Stuart Nancy Chief Operating Officer |
73,233 | $0 | $0 | 0 (Direct) |
View |
| 2023-02-15 Sale |
2023-02-16 08:51 am |
CONCERT PHARMACEUTICALS INC. | CNCE | Stuart Nancy Chief Operating Officer |
6,048 | $8.33 | $50,380 | 262,596 (Direct) |
View |
| 2023-01-30 Sale |
2023-01-31 08:30 am |
CONCERT PHARMACEUTICALS INC. | CNCE | Stuart Nancy Chief Operating Officer |
13,200 | $8.35 | $110,220 | 268,644 (Direct) |
View |
| 2023-01-06 Sale |
2023-01-09 4:17 pm |
CONCERT PHARMACEUTICALS INC. | CNCE | Stuart Nancy Chief Operating Officer |
2,893 | $7.25 | $20,974 | 281,844 (Direct) |
View |
| 2022-02-14 Sale |
2022-02-16 08:03 am |
CONCERT PHARMACEUTICALS INC. | CNCE | Stuart Nancy Chief Operating Officer |
6,049 | $3.08 | $18,631 | 284,737 (Direct) |
View |
| 2022-01-05 Sale |
2022-01-07 4:20 pm |
CONCERT PHARMACEUTICALS INC. | CNCE | Stuart Nancy Chief Operating Officer |
2,894 | $3.19 | $9,232 | 170,386 (Direct) |
View |
| 2021-02-16 Sale |
2021-02-17 9:34 pm |
CONCERT PHARMACEUTICALS INC. | CNCE | Stuart Nancy Chief Operating Officer |
6,049 | $7.32 | $44,279 | 173,280 (Direct) |
View |
| 2020-06-22 Sale |
2020-06-24 09:02 am |
CONCERT PHARMACEUTICALS INC. | CNCE | Stuart Nancy Chief Operating Officer |
10,295 | $11.34 | $116,694 | 157,629 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-10-03 Option Award |
2024-10-04 4:07 pm |
N/A 2034-10-02 |
KalVista Pharmaceuticals Inc. | KALV | Stuart Nancy Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2023-09-26 Option Award |
2023-09-28 4:54 pm |
N/A 2033-09-25 |
KalVista Pharmaceuticals Inc. | KALV | Stuart Nancy Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2023-03-06 Equity Swap |
2023-03-06 11:40 am |
N/A N/A |
CONCERT PHARMACEUTICALS INC. | CNCE | Stuart Nancy Chief Operating Officer |
167,963 | $0 | 0 (Direct) |
View |
| 2022-10-13 Option Award |
2022-10-17 6:37 pm |
N/A 2032-10-12 |
KalVista Pharmaceuticals Inc. | KALV | Stuart Nancy Director |
10,000 | $0 | 10,000 (Direct) |
View |
| 2022-01-28 Option Award |
2022-02-01 4:06 pm |
N/A N/A |
CONCERT PHARMACEUTICALS INC. | CNCE | Stuart Nancy Chief Operating Officer |
120,400 | $0 | 290,786 (Direct) |
View |
| 2021-03-18 Option Award |
2021-03-19 7:49 pm |
N/A 2031-03-17 |
KalVista Pharmaceuticals Inc. | KALV | Stuart Nancy Director |
14,000 | $0 | 14,000 (Direct) |
View |
| 2021-01-05 Option Award |
2021-01-07 4:38 pm |
N/A 2031-01-04 |
CONCERT PHARMACEUTICALS INC. | CNCE | Stuart Nancy Chief Operating Officer |
73,550 | $0 | 231,179 (Direct) |
View |
| 2020-06-22 Exercise |
2020-06-24 09:02 am |
N/A 2020-12-14 |
CONCERT PHARMACEUTICALS INC. | CNCE | Stuart Nancy Chief Operating Officer |
21,238 | $0 | 157,629 (Direct) |
View |
| 2020-06-22 Exercise |
2020-06-24 09:02 am |
N/A N/A |
CONCERT PHARMACEUTICALS INC. | CNCE | Stuart Nancy Chief Operating Officer |
21,238 | $3.79 | 157,629 (Direct) |
View |